MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Natera EBITDA per Share 2011-2026 | NTRA
Annual EBITDA per Share Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.33 | -5.05 | -2.56 | -1.77 | -1.85 | -2.38 | -1.75 | -2.07 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.75 | -5.33 | -2.85 |
Quarterly EBITDA per Share Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | -1.4 | - | -1.62 | -1.31 | -0.7 | - | -0.61 | -0.6 | -0.42 | - | -0.22 | -0.36 | -0.47 | - | -0.36 | -0.43 | -0.53 | - | -0.38 | -0.47 | -0.62 | - | -0.43 | -0.39 | -0.17 | - | -0.36 | -2.27 | -0.88 | - | 1.74 | 0.23 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.74 | -2.27 | -0.543 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.49 | $ 118.25 | -1.27 % | $ 35.9 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 22.5 | 9.44 % | $ 242 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 22.42 | 27.6 % | $ 1.19 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 1.46 | 2.82 % | $ 1.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 24.56 | -0.24 % | $ 682 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 176.94 | -2.0 % | $ 8.77 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 193.78 | -2.18 % | $ 138 B | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 132.72 | 0.35 % | $ 21.1 B | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 16.13 | -0.25 % | $ 488 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 28.63 | -1.58 % | $ 20 B |  Niderland |
 |
Medpace Holdings
MEDP
|
19.5 | $ 515.65 | -0.56 % | $ 14.9 B | USA |
 |
Guardant Health
GH
|
-3.17 | $ 85.7 | 0.99 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
-361 | $ 2.83 | -3.41 % | $ 91.8 K | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.2 | 4.27 % | $ 5.05 M | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 115.58 | -0.79 % | $ 9.53 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 266.36 | -0.14 % | $ 22.2 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 125.25 | 1.44 % | $ 5.86 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 83.92 | -0.02 % | $ 5.66 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 5.0 | -3.66 % | $ 463 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 8.16 | -5.99 % | $ 1.05 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.24 | -1.91 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 191.46 | 0.02 % | $ 21.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.27 | $ 5.17 | 0.58 % | $ 4.07 M | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 17.62 | -1.23 % | $ 394 M | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
-8.44 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
0.11 | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
6.54 | - | -0.91 % | $ 14.7 B | USA |